The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what’s in it for African and Middle Eastern rheumatologists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what’s in it for African and Middle Eastern rheumatologists

Published:2012-08-09 Issue:9 Volume:31 Page:1281-1287
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Alawadhi Adel,Alawneh Khaldoon,Alzahrani Zeyad Ahmed

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-012-2040-2.pdf

Reference39 articles.

1. Wolbink GJ, Aarden LA, Dijkmans BA (2009) Dealing with immunogenicity of biologicals: assessment and clinical relevance. Curr Opin Rheumatol 21:211–215

2. EU summary of product characteristics: Remicade (2012) Centocor BV, Leiden

3. EU summary of product characteristics: Humira (2012) Abbott Biotechnology Deutschland GmBH, Wiesbaden

4. Prescribing information: Rituximab (2012). Biogen Idec Inc and Genentech, South San Francisco

5. EU summary of product characteristics: Enbrel (2012) Pfizer, Hampshire

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess;Frontiers in Pharmacology;2023-07-24

2. Anti-adalimumab Antibodies in Patients with Non-infectious Ocular Inflammatory Disease: A Case Series;Ocular Immunology and Inflammation;2021-07-16

3. Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC–MS/MS;International Immunopharmacology;2015-09

4. Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis;BioDrugs;2015-08

5. A novel anti-TNF scFv constructed with human antibody frameworks and antagonistic peptides;Immunologic Research;2015-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3